ALDX Operating Cash Flow (Statement)

Aldeyra Therapeutics Inc · Operating Cash Flow (Statement)

ALDX logo

ALDX Operating Cash Flow (Statement)

Latest reported-$4.59M
ALDX Quarterly Cash from Operations (-$160.40K → -$4.59M)
High-resolution chart · PNG

ALDX operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aldeyra Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-4,589,422
-5,110,089
-5,299,345
-7,021,416
-8,555,222
-12,469,699
-12,036,845
-7,974,917
-13,224,298
-9,972,687
500,440
-8,024,914
-13,357,836
-9,443,818
-11,231,177
-12,574,218
-19,958,593
-12,873,199
-11,577,699
-8,434,100
-9,072,367
-13,471,741
-8,317,197
-6,237,452
-7,579,054
-15,359,752
-11,226,323
-8,315,046
-12,810,879
-12,631,978
-7,968,175
-7,688,672
-6,245,691
-7,954,593
-5,018,517
-4,705,604
-5,311,898
-4,186,843
-3,909,462
-3,503,568
-3,253,124
-4,481,358
-2,983,125
-2,882,938
-1,601,826
-1,843,864
-1,606,879
-1,210,769
-894,454
-1,063,892
-601,149
-516,686
-290,745
-298,021
-160,400
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.